Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 1 |
2021 | 5 |
2022 | 2 |
2024 | 0 |
PubMed for Bookshelf ID: 5530834
7 results
Results by year
Filters applied: . Clear all
Page 1
Trilaciclib prior to gemcitabine plus carboplatin for metastatic triple-negative breast cancer: phase III PRESERVE 2.
Future Oncol. 2022 Oct;18(33):3701-3711. doi: 10.2217/fon-2022-0773. Epub 2022 Sep 22.
Future Oncol. 2022.
PMID: 36135712
Free article.
Trilaciclib (Cosela) for prevention of chemotherapy-related myelosuppression.
[No authors listed]
[No authors listed]
Med Lett Drugs Ther. 2021 Nov 1;63(1636):174-175.
Med Lett Drugs Ther. 2021.
PMID: 35085207
No abstract available.
Item in Clipboard
Properties of FDA-approved small molecule protein kinase inhibitors: A 2022 update.
Roskoski R Jr.
Roskoski R Jr.
Pharmacol Res. 2022 Jan;175:106037. doi: 10.1016/j.phrs.2021.106037. Epub 2021 Dec 15.
Pharmacol Res. 2022.
PMID: 34921994
Review.
Item in Clipboard
Trilaciclib: First Approval.
Dhillon S.
Dhillon S.
Drugs. 2021 May;81(7):867-874. doi: 10.1007/s40265-021-01508-y.
Drugs. 2021.
PMID: 33861388
Review.
Item in Clipboard
Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive-stage small cell lung cancer: A multicentre, randomised, double-blind, placebo-controlled Phase II trial.
Daniel D, Kuchava V, Bondarenko I, Ivashchuk O, Reddy S, Jaal J, Kudaba I, Hart L, Matitashvili A, Pritchett Y, Morris SR, Sorrentino JA, Antal JM, Goldschmidt J.
Daniel D, et al.
Int J Cancer. 2021 May 15;148(10):2557-2570. doi: 10.1002/ijc.33453. Epub 2021 Jan 12.
Int J Cancer. 2021.
PMID: 33348420
Free PMC article.
Item in Clipboard
Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study.
Hart LL, Ferrarotto R, Andric ZG, Beck JT, Subramanian J, Radosavljevic DZ, Zaric B, Hanna WT, Aljumaily R, Owonikoko TK, Verhoeven D, Xiao J, Morris SR, Antal JM, Hussein MA.
Hart LL, et al.
Adv Ther. 2021 Jan;38(1):350-365. doi: 10.1007/s12325-020-01538-0. Epub 2020 Oct 29.
Adv Ther. 2021.
PMID: 33123968
Free PMC article.
Clinical Trial.
Item in Clipboard
Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trial.
Tan AR, Wright GS, Thummala AR, Danso MA, Popovic L, Pluard TJ, Han HS, Vojnović Ž, Vasev N, Ma L, Richards DA, Wilks ST, Milenković D, Yang Z, Antal JM, Morris SR, O'Shaughnessy J.
Tan AR, et al.
Lancet Oncol. 2019 Nov;20(11):1587-1601. doi: 10.1016/S1470-2045(19)30616-3. Epub 2019 Sep 28.
Lancet Oncol. 2019.
PMID: 31575503
Clinical Trial.
Item in Clipboard
Cite
Cite